Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Insulin Resistance or Prediabetes If you have insulin resistance, prediabetes, or metabolic syndrome, GLP-1 medications were originally developed for blood sugar management
Vilsbll T, Bain SC, Leiter LA, et al
Benefits (Research Focus) Triple receptor agonism studied for simultaneous activation of GLP-1, GIP, and glucagon receptors Body composition research investigated for fat-mass and lean-mass partitioning in DIO rodent models Glycemic endpoints examined for fasting glucose and HbA1c parameters in T2D research models Energy expenditure explored for glucagon-mediated thermogenic effects unique among incretin analogs Long-acting profile C20 fatty diacid albumin-binding chemistry for extended half-life research What Researchers Look At Receptor binding affinity and selectivity across GLP-1R / GIPR / GCGR cAMP activation curves in cell lines expressing each receptor subtype Food intake, body weight, and adipose-tissue change in DIO rodent models Hepatic steatosis, ALT/AST, and liver fat fraction endpoints Comparative pharmacology versus semaglutide, tirzepatide, and other incretin analogs Quick Specs Form: Lyophilized white powder Net Peptide Content: 10 mg per vial Quantity: 1 vial Appearance: White to off-white lyophilizate Reconstitution: Bacteriostatic or sterile water (added by the end researcher) Purity: 99% by HPLC Identity: MS-verified (per COA) Storage: Protect from light Identity Basics Compound: Retatrutide Synonyms: LY3437943
Reduced L-glutathione is not inherently destroyed during digestion
How It Fits Your Day Take Glutathione Formula daily as part of your supplement routinealongside meals and other foundational nutrientsto support ongoing nutritional balance
US$ 23.26
US$ 26.65
US$ 24.70
US$ 21.36
US$ 27.74
US$ 27.82
US$ 22.63
US$ 20.25
US$ 20.83
US$ 26.06
